13G Filing: Sabby Capital and Interpace Diagnostics Group Inc. (IDXG)

Page 6 of 8 – SEC Filing

( (ii)
Shared power to vote or to direct the vote
1,339,766
,( (iii)
Sole power to dispose or to direct the disposition of
0
,( (iv)
Shared power to dispose or to direct the disposition of
1,339,766
.As calculated in accordance with Rule 13d-3 of the Securities Exchange
Act of 1934, as amended, (i) Sabby Healthcare Master Fund,
Ltd. beneficially owns 120,476 shares of the Issuer’s common stock
(Common Stock), representing approximately 0.45% of the Common Stock,
and (ii) Sabby Management, LLC and Hal Mintz each beneficially own
1,339,766 shares of the Common Stock, representing approximately 4.99% of
the Common Stock. Sabby Management, LLC and Hal Mintz do not directly own
any shares of Common Stock, but each indirectly owns 1,339,766 shares of
Common Stock. Sabby Management, LLC, a Delaware limited liability company,
indirectly owns 1,339,766 shares of Common Stock because it serves as the
investment manager of Sabby Healthcare Master Fund, Ltd and Sabby
volatility Warrant Master Fund, Ltd. Mr. Mintz indirectly owns 1,339,766
shares of Common Stock in his capacity as manager of Sabby Management, LLC.

Item 5.
Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the
following [X].

Follow Interpace Biosciences Inc. (NASDAQ:IDXG)